Abstract
Diagnosis of reflux esophagitis can be made by endoscopic examination, when erosions or ulcerations are found in between the distal esophagus and the Z line. The most important role of endoscopic examination is to evaluate the severity and presence of complications by this chronic disease. Endoscopy can also differentiate other diagnoses with reflux-like symptoms, such as viral or eosinophilic esophagitis. Evaluation with endoscopy should especially be done for patients with weight loss, dysphagia, or vomiting. Barrett’s esophagus is the replacement of squamous epithelium with columnar mucosa by chronic exposure of acid. Endoscopy is the principal method for the evaluation and diagnosis of Barrett’s esophagus. Biopsy to confirm intestinal metaplasia in order to diagnose Barrett’s esophagus should be done.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Lower Esophageal Sphincter
- Intestinal Metaplasia
- Reflux Esophagitis
- Gastroesophageal Junction
- Distal Esophagus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Diagnosis of reflux esophagitis can be made by endoscopic examination, when erosions or ulcerations are found in between the distal esophagus and the Z line. The most important role of endoscopic examination is to evaluate the severity and presence of complications by this chronic disease. Endoscopy can also differentiate other diagnoses with reflux-like symptoms, such as viral or eosinophilic esophagitis. Evaluation with endoscopy should especially be done for patients with weight loss, dysphagia, or vomiting. Barrett’s esophagus is the replacement of squamous epithelium with columnar mucosa by chronic exposure of acid. Endoscopy is the principal method for the evaluation and diagnosis of Barrett’s esophagus. Biopsy to confirm intestinal metaplasia in order to diagnose Barrett’s esophagus should be done.
4.1 Pathophysiology
Pathologic reflux of gastric contents develops when the refluxate overwhelms the antireflux barriers of the gastroesophageal junction. The primary antireflux mechanism is the lower esophageal sphincter (LES) that is contracted to sustain a pressure above gastric pressure. Anatomic disruption of the gastroesophageal junction, commonly associated with a hiatal hernia (Fig. 4.1), contributes to the pathogenesis of reflux disease by impairing LES function [1]. Hiatal hernia is especially important in patients with severe esophagitis, peptic stricture, or Barrett’s esophagus [2]. Chronic low LES pressure is the predominant mechanism in GERD patients with severe reflux, and impaired esophageal clearance also can be another pathophysiology as in patients with scleroderma (Fig. 4.2).
4.2 Clinical Characteristics
Heartburn and regurgitation is the typical clinical picture of GERD (Table 4.1) [3]. The presence of “alarm signs”—dysphagia, odynophagia, weight loss, family history of upper gastrointestinal (GI) tract cancers, persistent nausea and emesis, long duration of symptoms (>10 years), and incomplete response to treatment—is warrant for the endoscopic evaluation.
4.3 Indication of Endoscopic Evaluation
Upper endoscopy allows not only the diagnosis of reflux esophagitis but also detection of any complications such as strictures or Barrett esophagus. Patients who do not respond to appropriate antisecretory medical therapy or who have other clinical signs suggestive of complicated GERD should be evaluated with endoscopy. Other diagnostic modalities such as ambulatory pH monitoring, esophageal manometry, or multichannel impedance testing should also be considered. Endoscopy is also the test of choice in patients who are at risk for Barrett’s esophagus. The indications for EGD in patients with GERD are listed in Table 4.2.
4.4 Diagnosis and Classification of Reflux Esophagitis
The endoscopic findings of reflux esophagitis are erosions or ulcerations involving the region from the distal esophagus to the Z line with a streaky pattern of spread, which are the result of esophageal mucosal injury and inflammation by acid exposure (Fig. 4.3). The presence of these typical endoscopic findings is diagnostic of GERD with a specificity of 90–95 %. At least 50 % of patients with reflux symptoms have normal esophageal endoscopic findings, which is named as nonerosive reflux disease.
The extent and severity of mucosal injury can be assessed endoscopically. The Los Angeles classification quantifies the length and circumference of mucosal breaks in the reflux esophagitis.
There are several classification systems for grading the endoscopic severity of erosive reflux esophagitis and associated complications. These classification systems have been primarily used in clinical trials to study the efficacy of medical therapy as treatment of reflux esophagitis. However, these systems are also useful in clinical practice for documenting disease severity. The most commonly used system is the Los Angeles classification (Table 4.3 and Fig. 4.4), which has good intra- and interobserver agreement as well as high correlation with the extent of esophageal acid exposure determined by 24-h pH monitoring. Description of the extent of endoscopic abnormalities can be used with an accepted grading system. Esophageal biopsy should be taken to exclude other diagnoses, including infectious etiologies and malignancy under the following conditions: immunocompromised patients, irregular or deep ulceration, presence of a mass lesion or nodularity, or an irregular or malignant-appearing stricture.
4.5 Minimal Change
There is another classification of GERD that the so-called minimal changes of mucosal edema, friability and erythema, whitish turbidity, fine granular change, exudates, mucosal friability, and invisibility of vessels are indicative of nonerosive reflux esophagitis. However, interobserver agreement of these findings is too low. To overcome the low agreement, new modalities have been evaluated, such as narrow band image (NBI) and magnification endoscopy. NBI system enhances visualization of microvasculature and mucosal patterns [4]. When it is combined with magnification, endoscopic abnormalities can be observed in the patients with NERD. Villous/ridge pit pattern, increased vascularity, microerosion, increased number of intrapapillary capillary loop, or tortuosity can be observed as a pattern of NERD (Fig. 4.5).
4.6 Treatment
4.6.1 Acid Suppressive Treatment
Proton pump inhibitors (PPIs) are the mainstay of both acute and maintenance treatment regimens for GERD. PPIs markedly diminish gastric acid secretion by inhibiting the final common pathway of the acid secretion pump (Fig. 4.6).
4.6.2 Fundoplication
Laparoscopic fundoplication is a commonly performed surgery for the treatment of reflux esophagitis. The appropriately performed fundoplication should be short, straight, parallel to the diaphragm, and at the top of the stomach (Fig. 4.7).
4.7 Sentinel Fold
The sentinel fold or polyp is a polypoid fold just distal to the esophagogastric junction (Fig. 4.8). Endoscopically, the sentinel fold is usually seen in an area of focal severe erosions or ulcerations. Biopsy of the fold reveals normal columnar epithelium with underlying acute and chronic inflammation. After aggressive antireflux therapy, the fold disappears or is significantly reduced in size.
4.8 Peptic Strictures
Peptic strictures develop in the region of gastroesophageal junction as a result of long-standing GERD and inflammation with fibrosis and scarring. Most strictures are short, but some may extend for several centimeters in the distal esophagus (Fig. 4.9). The earliest change is usually a thickening of the Z line, followed by concentric luminal narrowing.
4.9 Barrett’s Esophagus
Barrett’s esophagus is a condition in which the squamous epithelium of the distal esophagus is substituted with an intestinal-type columnar epithelium (specialized intestinal metaplasia, Fig. 4.10). This change occurs when the esophageal squamous epithelium which has been damaged by chronic reflux is replaced by metaplastic columnar epithelium. The importance of the finding and thus the necessity of identifying it, confirming it by biopsy, and monitoring its progression lie in the approximately 10 % risk of adenocarcinoma formation in the columnar-lined esophagus.
Endoscopy is the most accurate tool for the detection and diagnosis of Barrett’s esophagus. To endoscopically diagnose the presence of Barrett’s esophagus, the squamocolumnar junction and the gastroesophageal junction must be clearly identified. While proximal displacement of the squamocolumnar junction relative to the gastroesophageal junction is suggestive of Barrett’s esophagus, this endoscopic appearance of salmon-colored mucosa or an irregular Z line, either alone or in combination, is not sufficient to make the diagnosis. Biopsy specimens should always be obtained for histologic confirmation of columnar epithelium.
In patients with Barrett’s esophagus with no evidence of dysplasia on initial endoscopy, a repeated endoscopy should be performed within the next year. If no dysplasia is confirmed, these patients are considered to be at low risk to have their condition progress or develop cancer. Therefore, the interval for additional surveillance has been recommended to be every 3 years. If high-grade dysplasia is confirmed, the Barrett’s epithelium should be removed. Recently, alternative endoscopic treatment, such as endoscopic mucosal resection, thermal coagulation, or photodynamic therapy, has been successfully tried to cure the dysplastic Barrett’s esophagus.
The Prague classification was developed to standardize the classification of Barrett’s esophagus. In this classification, both the maximal length (M) (including tongues) of Barrett’s esophagus and the length of the circumferential Barrett’s segment (C) are measured during endoscopic examination (Fig. 4.11). These numbers can be used to follow-up the Barrett’s segment over time. This system has a high degree of overall validity for the endoscopic assessment of the visualized Barrett’s esophagus segment when it is >1 cm in length.
References
El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases oesophageal acid exposure. Gut. 2007;56:749–55.
Jones MP, Sloan SS, Rabine JC, et al. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:1711–7.
Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340–8.
Sharma P, Wani S, Bansal A, et al. A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:454–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Park, J.M. (2014). Reflux Esophagitis and Barrett’s Esophagus. In: Chun, H., Yang, SK., Choi, MG. (eds) Clinical Gastrointestinal Endoscopy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35626-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-35626-1_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35625-4
Online ISBN: 978-3-642-35626-1
eBook Packages: MedicineMedicine (R0)